Nyrada Inc -Nyrada Successfully Raises $1.755 Million via Placement

Highlights:
•Nyrada has successfully raised $1.755 million of new equity capital (before costs).
•Nyrada Directors will subscribe for an additional $0.210 million of new equity capital, subject to shareholder approval.
•Funds to be used for pre-clinical GLP study and Phase I human clinical trial of NYR-BI03, its lead Brain Injury Program drug candidate.
•GLP study commencing in coming weeks followed by a Phase I study in 2HCY2024.